Customer:
    US FDA

Requirement:
    FDA wanted to develop a Genomic Reviewer Desktop (GRD) – A standard for its reviewers to analyze  Voluntary Exploratory Data Submission VXDS submissions.

Strand Solution:
    Strand collaborated with the FDA to develop a desktop environment for its VXDS program reviewers.  GRD has hooks into several third-party tools and allows for query,  analysis, and visual presentation of results.  

Benefits:
    GRD improves the efficiency of processing data submissions for the VXDS program.